CLINICAL RESEARCH: ACUTE CORONARY SYNDROMES
Acute Clopidogrel Use and Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
Rajendra H. Mehta, MD, MS, FACC*,*,
Matthew T. Roe, MD, MHS, FACC*,
Jyotsna Mulgund, MS*,
E. Magnus Ohman, MD, FACC ,
Christopher P. Cannon, MD, FACC ,
W. Brian Gibler, MD ,
Charles V. Pollack, Jr, MD, MA||,
Sidney C. Smith, Jr, MD, FACC,
T. Bruce Ferguson, MD¶ and
Eric D. Peterson, MD, MPH, FACC*
* Division of Cardiology and the Duke Clinical Research Institute, Durham, North Carolina
University of North Carolina School of Medicine, Chapel Hill, North Carolina
TIMI Study Group, Brigham and Women's Hospital, Boston, Massachusetts
University of Cincinnati College of Medicine, Cincinnati, Ohio
|| University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
¶ Louisiana State University Health Science Center, New Orleans, Louisiana
Manuscript received August 30, 2005;
revised manuscript received March 17, 2006,
accepted March 21, 2006.
* Reprint requests and correspondence: Dr. Rajendra H. Mehta, Box 17969, Duke Clinical Research Institute, Durham, North Carolina 27715 (Email: mehta007{at}dcri.duke.edu).
OBJECTIVES: We sought to characterize patterns of clopidogrel use before coronary artery bypass grafting (CABG) and examine the drug's impact on risks for postoperative transfusions among patients with non–ST-segment elevation acute coronary syndromes (NSTE ACS).
BACKGROUND: Adherence in community practice to American College of Cardiology/American Heart Association guidelines for clopidogrel use among NSTE ACS patients has not been previously characterized.
METHODS: We evaluated 2,858 NSTE ACS patients undergoing CABG at 264 hospitals participating in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative. We examined the patterns of acute clopidogrel therapy and its association with bleeding risks among those having "early" CABG  5 days and again among those having "late" surgery >5 days after catheterization.
RESULTS: Within 24 h of admission, 852 patients (30%) received clopidogrel. In contrast to national guidelines, 87% of clopidogrel-treated patients underwent CABG 5 days after treatment. Among those receiving CABG within 5 days of last treatment, the use of clopidogrel was associated with a significant increase in blood transfusions (65.0% vs. 56.9%, adjusted odds ratio [OR] 1.36, 95% confidence interval [CI] 1.10 to 1.68) as well as the need for transfusion of  4 U of blood (27.7% vs. 18.4%, OR 1.70, 95% CI 1.32 to 2.19). In contrast, acute clopidogrel therapy was not associated with higher bleeding risks if CABG was delayed >5 days (adjusted OR 1.18, 95% CI 0.54 to 2.58).
CONCLUSIONS: Despite guideline recommendations, the overwhelming majority of NSTE ACS patients treated with acute clopidogrel needing CABG have their surgery within 5 days of treatment. A failure to delay surgery is associated with increased blood transfusion requirements that must be weighed against the potential clinical and economic impacts of such delays.
|
Abbreviations and Acronyms
| | ACC/AHA = American College of Cardiology/American Heart Association | | CABG = coronary artery bypass graft | | CI = confidence interval | | CRUSADE = Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines Initiative | | CURE = Clopidogrel in Unstable Angina to Prevent Recurrent Events trial | | GP = glycoprotein | | NSTE ACS = non–ST-segment elevation acute coronary syndromes | | OR = odds ratio | | RBC = red blood cell | | RR = relative risk |
|
This article has been cited by other articles:
|
|
|
|
 
S. F. Aranki and S. C. Body
Antiplatelet agents used for early intervention in acute coronary syndrome: Myocardial salvage versus bleeding complications.
J. Thorac. Cardiovasc. Surg.,
October 1, 2009;
138(4):
807 - 810.e7.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Bonaca, P. G. Steg, L. J. Feldman, J. F. Canales, J. J. Ferguson, L. Wallentin, R. M. Califf, R. A. Harrington, and R. P. Giugliano
Antithrombotics in acute coronary syndromes.
J. Am. Coll. Cardiol.,
September 8, 2009;
54(11):
969 - 984.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Patel and D. Mascarenhas
Rethinking loading dose clopidogrel in light of increased bleeding complications in bypass patients.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1):
90 - 90.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ebrahimi, C. Dyke, R. Mehran, S. V. Manoukian, F. Feit, D. A. Cox, B. J. Gersh, E. M. Ohman, H. D. White, J. W. Moses, et al.
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
J. Am. Coll. Cardiol.,
May 26, 2009;
53(21):
1965 - 1972.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Barker and H. V. Anderson
Acute coronary syndromes: don't bypass the clopidogrel.
J. Am. Coll. Cardiol.,
May 26, 2009;
53(21):
1973 - 1974.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Berger, C. B. Frye, Q. Harshaw, F. H. Edwards, S. R. Steinhubl, and R. C. Becker
Impact of Clopidogrel in Patients With Acute Coronary Syndromes Requiring Coronary Artery Bypass Surgery: A Multicenter Analysis
J. Am. Coll. Cardiol.,
November 18, 2008;
52(21):
1693 - 1701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Douketis, P. B. Berger, A. S. Dunn, A. K. Jaffer, A. C. Spyropoulos, R. C. Becker, and J. Ansell
The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest,
June 1, 2008;
133(6_suppl):
299S - 339S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-P. Bassand
Unmet needs in antiplatelet therapy
Eur. Heart J. Suppl.,
May 1, 2008;
10(suppl_D):
D3 - D11.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. P. Giugliano and E. Braunwald
The Year in Non ST-Segment Elevation Acute Coronary Syndrome
J. Am. Coll. Cardiol.,
October 2, 2007;
50(14):
1386 - 1395.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. V Hernandez, C. M Westerhout, E. W Steyerberg, J. P A Ioannidis, H. Bueno, H. White, P. Theroux, D. J Moliterno, P. W Armstrong, R. M Califf, et al.
The authors' reply:
Heart,
October 1, 2007;
93(10):
1293 - 1293.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
e1 - e157.
[Full Text]
[PDF]
|
|
|
|
